The phrase "addition to the indication" is not correct and may cause confusion in written English.
It could be used when discussing supplementary information related to a specific indication, but the phrasing is awkward.
Example: "In addition to the indication provided, we must also consider the patient's history."
Alternatives: "in addition to the signal" or "supplementary to the indication".
In addition to the indications provided by these estimates, policy programmers should also consider their own knowledge of the epidemic and other available data to define health policy and to explain disparities observed within a specific country.
Since the tables are numbered, we will use these table numbers in addition to the item indication.
In addition to the classic indication for the subxiphoid window to study the vena cava and pericardium, this view can be used to study right and left ventricular morphology and function, but does not provide accurate hemodynamic Doppler information.
On one hand, in addition to the present indication for the use of anti-EGFR moAbs, the results from a recent phase III randomised trial (Van Cutsem et al, 2009) led to the approval of cetuximab for KRAS codon 12 and 13 wild-type patients also in the first-line setting.
In addition to the AAPD indications, the Helsinki PDS indications for the use of DGA with children and adolescents also recommend this approach for adolescents who are at risk of alienation from society due to dental problems and the need for extensive dental treatment and for adults with intellectual, physical, mental or medical disabilities that could be overcome this way.
The questionnaire included, in addition to the basic indications, i.e., extraction or monitoring, "another conduct" option to be described by the respondents.
In addition to the above indications, we have reviewed the clinical efficacy in newly diagnosed myeloma, MDS/AML, NHL, CLL, and Hodgkin lymphoma.
In addition to the licensed indications, preclinical evidence suggests CBD has therapeutic potential in diseases associated with inflammation, oxidative stress, gastrointestinal disturbances, neurodegeneration, cancer, diabetes, and nociception.
In addition to the FDA indications for the prevention of acute and delayed CINV (July 2003), palonosetron received FDA approval in March 2008 for the prevention of PONV based on 2 randomized, double-blind studies.
In addition to the underlying indications for use of antihypertensive drugs, pre-existing diabetes before the index pregnancy and being overweight during pregnancy were probably the two most important potential confounders or effect modifiers.
